This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Furumoto, H.
Right arrow Articles by Cheng, S.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furumoto, H.
Right arrow Articles by Cheng, S.-Y.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, January 2005, p. 124-135, Vol. 25, No. 1
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.1.124-135.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

An Unliganded Thyroid Hormone ß Receptor Activates the Cyclin D1/Cyclin-Dependent Kinase/Retinoblastoma/E2F Pathway and Induces Pituitary Tumorigenesis

Hiroko Furumoto,1,{dagger} Hao Ying,1,{dagger} G. V. R. Chandramouli,2 Li Zhao,1 Robert L. Walker,3 Paul S. Meltzer,3 Mark C. Willingham,4 and Sheue-Yann Cheng1*

Laboratory of Molecular Biology,1 Advanced Technology Center, Center for Cancer Research, National Cancer Institute,2 Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland,3 Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina4

Received 12 July 2004/ Returned for modification 12 August 2004/ Accepted 6 October 2004

Thyroid-stimulating hormone (TSH)-secreting tumors (TSH-omas) are pituitary tumors that constitutively secrete TSH. The molecular genetics underlying this abnormality are not known. We discovered that a knockin mouse harboring a mutated thyroid hormone receptor (TR) ß (PV; TRßPV/PV mouse) spontaneously developed TSH-omas. TRßPV/PV mice lost the negative feedback regulation with highly elevated TSH levels associated with increased thyroid hormone levels (3,3',5-triiodo-L-thyronine [T3]). Remarkably, we found that mice deficient in all TRs (TR{alpha}1–/– TRß–/–) had similarly increased T3 and TSH levels, but no discernible TSH-omas, indicating that the dysregulation of the pituitary-thyroid axis alone is not sufficient to induce TSH-omas. Comparison of gene expression profiles by cDNA microarrays identified overexpression of cyclin D1 mRNA in TRßPV/PV but not in TR{alpha}1–/– TRß–/– mice. Overexpression of cyclin D1 protein led to activation of the cyclin D1/cyclin-dependent kinase/retinoblastoma protein/E2F pathway only in TRßPV/PV mice. The liganded TRß repressed cyclin D1 expression via tethering to the cyclin D1 promoter through binding to the cyclic AMP response element-binding protein. That repression effect was lost in mutant PV, thereby resulting in constitutive activation of cyclin D1 in TRßPV/PV mice. The present study revealed a novel molecular mechanism by which an unliganded TRß mutant acts to contribute to pituitary tumorigenesis in vivo and provided mechanistic insights into the understanding of pathogenesis of TSH-omas in patients.


* Correspondending author. Mailing address: Laboratory of Molecular Biology, National Cancer Institute, 37 Convent Dr., Rm. 5128, Bethesda, MD 20892-4264. Phone: (301) 496-4280. Fax: (301) 480-9676. E-mail: sycheng{at}helix.nih.gov.

{dagger} H.F. and H.Y. made equal contributions.


Molecular and Cellular Biology, January 2005, p. 124-135, Vol. 25, No. 1
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.1.124-135.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Araki, O., Ying, H., Zhu, X. G., Willingham, M. C., Cheng, S. Y. (2009). Distinct Dysregulation of Lipid Metabolism by Unliganded Thyroid Hormone Receptor Isoforms. Mol. Endocrinol. 23: 308-315 [Abstract] [Full Text]  
  • Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeold, A., Bianco, A. C. (2008). Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling. Endocr. Rev. 29: 898-938 [Abstract] [Full Text]  
  • Guigon, C. J., Zhao, L., Lu, C., Willingham, M. C., Cheng, S.-y. (2008). Regulation of {beta}-Catenin by a Novel Nongenomic Action of Thyroid Hormone {beta} Receptor. Mol. Cell. Biol. 28: 4598-4608 [Abstract] [Full Text]  
  • Wulf, A., Wetzel, M. G, Kebenko, M., Kroger, M., Harneit, A., Merz, J., Weitzel, J. M (2008). The role of thyroid hormone receptor DNA binding in negative thyroid hormone-mediated gene transcription. J Mol Endocrinol 41: 25-34 [Abstract] [Full Text]  
  • Lu, C., Willingham, M. C., Furuya, F., Cheng, S.-y. (2008). Activation of Phosphatidylinositol 3-Kinase Signaling Promotes Aberrant Pituitary Growth in a Mouse Model of Thyroid-Stimulating Hormone-Secreting Pituitary Tumors. Endocrinology 149: 3339-3345 [Abstract] [Full Text]  
  • Furuya, F., Lu, C., Willingham, M. C., Cheng, S.-y. (2007). Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer. Carcinogenesis 28: 2451-2458 [Abstract] [Full Text]  
  • Dentice, M., Luongo, C., Huang, S., Ambrosio, R., Elefante, A., Mirebeau-Prunier, D., Zavacki, A. M., Fenzi, G., Grachtchouk, M., Hutchin, M., Dlugosz, A. A., Bianco, A. C., Missero, C., Larsen, P. R., Salvatore, D. (2007). Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc. Natl. Acad. Sci. USA 104: 14466-14471 [Abstract] [Full Text]  
  • Furuya, F., Guigon, C. J., Zhao, L., Lu, C., Hanover, J. A., Cheng, S.-y. (2007). Nuclear Receptor Corepressor Is a Novel Regulator of Phosphatidylinositol 3-Kinase Signaling. Mol. Cell. Biol. 27: 6116-6126 [Abstract] [Full Text]  
  • Kim, C. S., Ying, H., Willingham, M. C., Cheng, S.-y. (2007). The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer. Carcinogenesis 28: 932-939 [Abstract] [Full Text]  
  • Ying, H., Araki, O., Furuya, F., Kato, Y., Cheng, S.-Y. (2007). Impaired Adipogenesis Caused by a Mutated Thyroid Hormone {alpha}1 Receptor. Mol. Cell. Biol. 27: 2359-2371 [Abstract] [Full Text]  
  • Kim, C. S., Furuya, F., Ying, H., Kato, Y., Hanover, J. A., Cheng, S.-y. (2007). Gelsolin: A Novel Thyroid Hormone Receptor-{beta} Interacting Protein that Modulates Tumor Progression in a Mouse Model of Follicular Thyroid Cancer. Endocrinology 148: 1306-1312 [Abstract] [Full Text]  
  • Flamant, F., Gauthier, K., Samarut, J. (2007). Thyroid Hormones Signaling Is Getting More Complex: STORMs Are Coming. Mol. Endocrinol. 21: 321-333 [Abstract] [Full Text]  
  • Sukocheva, O A, Carpenter, D O (2006). Anti-apoptotic effects of 3,5,3'-tri-iodothyronine in mouse hepatocytes.. J Endocrinol 191: 447-458 [Abstract] [Full Text]  
  • Nygard, M., Becker, N., Demeneix, B., Pettersson, K., Bondesson, M. (2006). Thyroid hormone-mediated negative transcriptional regulation of Necdin expression.. J Mol Endocrinol 36: 517-530 [Abstract] [Full Text]  
  • Furuya, F., Hanover, J. A., Cheng, S.-y. (2006). Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor. Proc. Natl. Acad. Sci. USA 103: 1780-1785 [Abstract] [Full Text]  
  • Ledda-Columbano, G. M., Molotzu, F., Pibiri, M., Cossu, C., Perra, A., Columbano, A. (2006). Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes. FASEB J. 20: 87-94 [Abstract] [Full Text]  
  • Ying, H., Furuya, F., Willingham, M. C., Xu, J., O'Malley, B. W., Cheng, S.-y. (2005). Dual Functions of the Steroid Hormone Receptor Coactivator 3 in Modulating Resistance to Thyroid Hormone. Mol. Cell. Biol. 25: 7687-7695 [Abstract] [Full Text]